BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang FM, Mo P, Yan X, Lin XY, Fu ZC. Present situation and prospect of immunotherapy for unresectable locally advanced esophageal cancer during peri-radiotherapy. World J Gastrointest Oncol 2024; 16(1): 1-7 [PMID: 38292836 DOI: 10.4251/wjgo.v16.i1.1]
URL: https://www.wjgnet.com/1948-5204/full/v16/i1/1.htm
Number Citing Articles
1
Dhivya Viswanathan, Rajakumar Govindasamy, Ekambaram Gayathiri. Molecular complexity of oral cancer: Implications for research and clinical practiceOral Oncology Reports 2024; 10: 100370 doi: 10.1016/j.oor.2024.100370
2
Liangyun Xie, Yafei Zhang, Xiedong Niu, Xiaomei Jiang, Yuan Kang, Xinyue Diao, Jinhai Fang, Yilin Yu, Jun Yao. A nomogram for predicting cancer-specific survival in patients with locally advanced unresectable esophageal cancer: development and validation studyFrontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1524439
3
Shunsuke A. Sakai, Koichi Saeki, SungGi Chi, Yamato Hamaya, Junyan Du, Masaki Nakamura, Hidehiro Hojo, Takashi Kojima, Yoshiaki Nakamura, Hideaki Bando, Motohiro Kojima, Ayako Suzuki, Yutaka Suzuki, Tetsuo Akimoto, Katsuya Tsuchihara, Hiroshi Haeno, Riu Yamashita, Shun-Ichiro Kageyama. Mathematical Modeling Predicts Optimal Immune Checkpoint Inhibitor and Radiotherapy Combinations and Timing of AdministrationCancer Immunology Research 2025; 13(3): 353 doi: 10.1158/2326-6066.CIR-24-0610